(Q46614182)

23 December 2017

title

Inhibition of protein phosphatase 1 by inhibitor-2 exacerbates progression of cardiac failure in a model with pressure overload (English)

1 reference

23 December 2017

author name string

Stephanie Grote-Wessels

1

1 reference

23 December 2017

Hideo A Baba

2

1 reference

23 December 2017

Peter Boknik

3

1 reference

23 December 2017

Ali El-Armouche

4

1 reference

23 December 2017

Larissa Fabritz

5

1 reference

23 December 2017

Hans-Jörg Gillmann

6

1 reference

23 December 2017

Dana Kucerova

7

1 reference

23 December 2017

Marek Matus

8

1 reference

23 December 2017

Frank U Müller

9

1 reference

23 December 2017

Joachim Neumann

10

1 reference

23 December 2017

Martina Schmitz

11

1 reference

23 December 2017

Frank Stümpel

12

1 reference

23 December 2017

Gregor Theilmeier

13

1 reference

23 December 2017

Jeremias Wohlschlaeger

14

1 reference

23 December 2017

Wilhelm Schmitz

15

1 reference

23 December 2017

Uwe Kirchhefer

16

1 reference

23 December 2017

publication date

3 May 2008

1 reference

23 December 2017

published in

Cardiovascular Research

1 reference

23 December 2017

volume

79

1 reference

23 December 2017

issue

3

1 reference

23 December 2017

page(s)

464-471

1 reference

23 December 2017

Nationwide survey on acute heart failure in cardiology ward services in Italy

cites work

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN113

Phospholamban: a crucial regulator of cardiac contractility

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN113

Troponin I phosphorylation plays an important role in the relaxant effect of beta-adrenergic stimulation in mouse hearts

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN113

Molecular aspects of adrenergic modulation of cardiac L-type Ca2+ channels.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN113

Phosphorylation and desensitization of the human beta 1-adrenergic receptor. Involvement of G protein-coupled receptor kinases and cAMP-dependent protein kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN113

Protein phosphatase activity is increased in a rat model of long-term beta-adrenergic stimulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN113

Type 1 phosphatase, a negative regulator of cardiac function

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN113

Evidence for isoproterenol-induced phosphorylation of phosphatase inhibitor-1 in the intact heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN113

Evidence for protein phosphatase inhibitor-1 playing an amplifier role in beta-adrenergic signaling in cardiac myocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN113

Enhanced cardiac function in mice overexpressing protein phosphatase Inhibitor-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN113

Interaction of inhibitor-2 with the catalytic subunit of type 1 protein phosphatase. Identification of a sequence analogous to the consensus type 1 protein phosphatase-binding motif

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN113

Segregation of atrial-specific and inducible expression of an atrial natriuretic factor transgene in an in vivo murine model of cardiac hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN113

Cardiac hypertrophy and impaired relaxation in transgenic mice overexpressing triadin 1

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN113

Smooth muscle-selective deletion of guanylyl cyclase-A prevents the acute but not chronic effects of ANP on blood pressure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN113

Overexpression of the catalytic subunit of protein phosphatase 2A impairs cardiac function

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN113

Transgenic triadin 1 overexpression alters SR Ca2+ handling and leads to a blunted contractile response to beta-adrenergic agonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN113

Time course and mechanisms of phosphorylation of phospholamban residues in ischemia-reperfused rat hearts. Dissociation of phospholamban phosphorylation pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN113

Impaired relaxation in transgenic mice overexpressing junctin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN113

Inhibition of protein phosphatase 1 by inhibitor-2 gene delivery ameliorates heart failure progression in genetic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN113

Regulation of type 1 protein phosphatase/inhibitor-2 complex by glycogen synthase kinase-3beta in intact cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN113

Inhibitory phosphorylation of glycogen synthase kinase-3 (GSK-3) in response to lithium. Evidence for autoregulation of GSK-3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN113

Progressive hypertrophy and heart failure in beta1-adrenergic receptor transgenic mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN113

Fibrosis, not cell size, delineates beta-myosin heavy chain reexpression during cardiac hypertrophy and normal aging in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN113

Cardiac hypertrophy induced by sustained beta-adrenoreceptor activation: pathophysiological aspects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN113

21 January 2018

Identifiers

DOI

10.1093/CVR/CVN113

1 reference

23 December 2017

PubMed ID

18453636

1 reference

23 December 2017